ES8500275A1 - Procedimiento de preparacion de los derivados de la xantina - Google Patents

Procedimiento de preparacion de los derivados de la xantina

Info

Publication number
ES8500275A1
ES8500275A1 ES524532A ES524532A ES8500275A1 ES 8500275 A1 ES8500275 A1 ES 8500275A1 ES 524532 A ES524532 A ES 524532A ES 524532 A ES524532 A ES 524532A ES 8500275 A1 ES8500275 A1 ES 8500275A1
Authority
ES
Spain
Prior art keywords
image
alkyl
hydrogen
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524532A
Other languages
English (en)
Other versions
ES524532A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of ES8500275A1 publication Critical patent/ES8500275A1/es
Publication of ES524532A0 publication Critical patent/ES524532A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE LA XANTINA, DE FORMULA GENERAL (I), Y DE SUS SALES DE ADICION CON ACIDOS APROPIADOS.CONSISTE EN CONDENSAR UN DERIVADO HALOGENADO DE FORMULA GENERAL (II), CON UN DERIVADO AMINADO DE FORMULA GENERAL (III).DE APLICACION EN TERAPEUTICA POR SUS PROPIEDADES BRONCODILATADORAS Y ANTIALERGICAS.
ES524532A 1982-07-28 1983-07-28 Procedimiento de preparacion de los derivados de la xantina Granted ES524532A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8213155A FR2531085A1 (fr) 1982-07-28 1982-07-28 Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
ES8500275A1 true ES8500275A1 (es) 1984-10-01
ES524532A0 ES524532A0 (es) 1984-10-01

Family

ID=9276395

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524532A Granted ES524532A0 (es) 1982-07-28 1983-07-28 Procedimiento de preparacion de los derivados de la xantina

Country Status (24)

Country Link
US (1) US4548820A (es)
EP (1) EP0103497B1 (es)
JP (1) JPS5942383A (es)
KR (1) KR870001268B1 (es)
AT (1) ATE17728T1 (es)
AU (1) AU560809B2 (es)
CA (1) CA1207766A (es)
DD (1) DD216934A5 (es)
DE (1) DE3362022D1 (es)
DK (1) DK157550C (es)
ES (1) ES524532A0 (es)
FR (1) FR2531085A1 (es)
GR (1) GR78891B (es)
HU (1) HU188353B (es)
IE (1) IE55773B1 (es)
IL (1) IL69362A (es)
MA (1) MA19860A1 (es)
NO (1) NO159091C (es)
NZ (1) NZ205035A (es)
OA (1) OA07508A (es)
PH (1) PH19275A (es)
PT (1) PT77110B (es)
SU (2) SU1240361A3 (es)
ZA (1) ZA835496B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.
FR2558162B1 (fr) * 1984-01-17 1986-04-25 Adir Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
HU197746B (en) * 1985-09-05 1989-05-29 Sandoz Ag Process for producing xantin derivatives and pharmaceutical compositions containing them
US4810706A (en) * 1985-12-20 1989-03-07 Recherche Syntex Piperazine derivatives of theophylline and theobromine
GB8716313D0 (en) * 1987-07-10 1987-08-19 Janssen Pharmaceutica Nv 2-(heterocyclylalkyl)imidazopyridines
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5290782A (en) * 1989-09-01 1994-03-01 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
FR2659656B1 (fr) * 1990-03-15 1994-09-09 Sanofi Sa Derives de pyrimidinedione-2,4 et medicaments les contenant.
DE4019892A1 (de) * 1990-06-22 1992-01-02 Boehringer Ingelheim Kg Neue xanthinderivate
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
JP2613355B2 (ja) * 1992-09-28 1997-05-28 協和醗酵工業株式会社 パーキンソン氏病治療剤
WO1994025462A1 (en) * 1993-05-03 1994-11-10 The United States Of America, Represented By The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
DE19702785A1 (de) * 1997-01-27 1998-07-30 Bayer Ag Neue cyclische Harnstoffderivate
DE60043318D1 (de) 1999-08-21 2010-01-14 Nycomed Gmbh Synergistische kombination von pumafentrine und salmeterol
KR20050115331A (ko) 2003-04-01 2005-12-07 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 불임증 포스포디에스터라제의 억제제
WO2004096228A1 (en) 2003-04-25 2004-11-11 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
US20050239759A1 (en) * 2004-04-16 2005-10-27 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor
JP2008517029A (ja) * 2004-10-22 2008-05-22 スミスクライン・ビーチャム・コーポレイション Ｈｍ７４ａ受容体活性を有するキサンチン誘導体
US20100029681A1 (en) * 2006-05-26 2010-02-04 Hassan Pajouhesh Heterocyclic compounds as calcium channel blockers
JP2008025761A (ja) * 2006-07-24 2008-02-07 Kanaflex Corporation 排水管更生用樹脂管
RU2333212C3 (ru) * 2007-03-29 2019-08-26 Общество С Ограниченной Ответственностью "Фармвинг" ПРОИЗВОДНЫЕ 1-И 7-[ω-(БЕНЗГИДРИЛ-4-ПИПЕРАЗИНИЛ-1)АЛКИЛ]-3-АЛКИЛКСАНТИНОВ, ОБЛАДАЮЩИЕ ПРОТИВОГИСТАМИННОЙ И АНТИАЛЛЕРГИЧЕСКОЙ АКТИВНОСТЬЮ
HUE031039T2 (en) 2007-03-29 2017-06-28 Joint-Stock Company Obninsk Chemical Pharmaceutical Company An antihistamine and an anti-allergenic agent and a method for its preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH409974A (de) * 1959-03-25 1966-03-31 Merckle Kg Chem Pharm L Verfahren zur Herstellung neuer therapeutisch wirksamer Coffeino-(8)-alkylendiamine
GB1133989A (en) * 1964-12-08 1968-11-20 Chugai Pharmaceutical Co Ltd Theophylline derivatives, their salts and process for preparing the same
FR7828M (es) * 1967-11-13 1970-05-25
JPS55118488A (en) * 1979-03-05 1980-09-11 Eisai Co Ltd Theobromine derivative and its preparation
JPS5618983A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Theophylline derivative and its preapration
US4426383A (en) * 1980-09-04 1984-01-17 Eisai Co., Ltd. Theophylline and theobromine derivatives
DE3046927A1 (de) * 1980-12-11 1982-07-15 Josef Dipl.-Chem.Dr.rer.nat. 1000 Berlin Klosa 8-dialkylaminoalkylaether-coffein-platin-komplexe , verfahren zu ihrer herstellung und sie enthaltende arzneimittel
ES8303412A1 (es) * 1981-10-06 1983-02-01 Invest Tecnica Aplicada Procedimiento de obtencion de nuevas xantinas con actividad farmacologica

Also Published As

Publication number Publication date
JPH0359903B2 (es) 1991-09-12
GR78891B (es) 1984-10-02
IE831762L (en) 1984-01-28
NO159091C (no) 1988-11-30
IL69362A0 (en) 1983-11-30
SU1245261A3 (ru) 1986-07-15
DK342883A (da) 1984-01-29
NO159091B (no) 1988-08-22
IE55773B1 (en) 1991-01-16
DK342883D0 (da) 1983-07-27
AU1736183A (en) 1984-02-02
JPS5942383A (ja) 1984-03-08
ZA835496B (en) 1984-03-28
ATE17728T1 (de) 1986-02-15
FR2531085A1 (fr) 1984-02-03
PT77110B (fr) 1986-01-27
US4548820A (en) 1985-10-22
KR870001268B1 (ko) 1987-06-30
AU560809B2 (en) 1987-04-16
EP0103497B1 (fr) 1986-01-29
EP0103497A1 (fr) 1984-03-21
DK157550B (da) 1990-01-22
NZ205035A (en) 1986-04-11
OA07508A (fr) 1985-03-31
NO832742L (no) 1984-01-30
KR840005445A (ko) 1984-11-12
DD216934A5 (de) 1985-01-02
HU188353B (en) 1986-04-28
PH19275A (en) 1986-02-21
FR2531085B1 (es) 1984-11-23
SU1240361A3 (ru) 1986-06-23
MA19860A1 (fr) 1984-04-01
ES524532A0 (es) 1984-10-01
IL69362A (en) 1986-07-31
CA1207766A (fr) 1986-07-15
DK157550C (da) 1990-06-11
PT77110A (fr) 1983-08-01
DE3362022D1 (en) 1986-03-13

Similar Documents

Publication Publication Date Title
ES8500275A1 (es) Procedimiento de preparacion de los derivados de la xantina
ES8605806A1 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
ES2002720A6 (es) Procedimiento para preparar 2-hidroxi-3-fenoxipropilaminas
DE3361100D1 (en) Disubstituted polymethylene imines, processes for their preparation and pharmaceutical compositions containing them
ES8401960A1 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
EP0186023A3 (en) Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them
PT76934B (en) Process for the preparation of novel cetene-thio-acetals
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
SE8300855L (sv) Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem
EP0173377A3 (en) Pyrimidone compounds, their preparation and pharmaceutical compositions containing them
ES8802311A1 (es) Procedimiento de preparacion de derivados del triazol y de sus sales de adicion con los acidos apropiados
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
DE3674250D1 (de) Phenylpyrazinderivate, verfahren zu deren herstellung, pharmazeutische zusammensetzung und verwendung.
DE3166645D1 (en) Dibenzoxazonine, dibenzoxazecine, dibenzoxaazacycloundecane derivatives and their corresponding thia- and aza derivatives, their preparation and pharmaceutical compositions

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303